Literature DB >> 9833722

Vasoplegic syndrome after open heart surgery.

W J Gomes1, A C Carvalho, J H Palma, C A Teles, J N Branco, M G Silas, E Buffolo.   

Abstract

BACKGROUND: A new form of postperfusion manifestation is detailed, a vasoplegic syndrome presenting in the postoperative period after cardiopulmonary bypass (CPB) heart surgery.
METHODS: This retrospective study included sixteen patients who underwent cardiovascular surgery using CPB and exhibited clinical and hemodynamic features compatible with vasoplegic syndrome. The technique of CPB was hypothermic (28 degrees C) in 15 and normothermic in 1 patient, and hypothermic blood cardioplegia was employed in all patients, except 1. The mean CPB time was 121 minutes, ranging from 80 to 210 minutes.
RESULTS: The patients presented a severe feature comprising hypotension, tachycardia, normal or elevated cardiac output, low systemic vascular resistance and decreased filling pressures. Fluid administration alone was not capable of restoring hemodynamic parameters. Physical examination revealed normal capillary filling at the extremities although oliguria and hypotension were observed. These patients needed a high dosage of vasoconstrictor drugs (norepinephrine) for blood pressure control but even high dose norepinephrine did not produce the classical situation of cool extremities and weak peripheral pulses, with increased morbidity and mortality. Severe systemic complications could develop if the vasoplegic syndrome persisted 36-48 hours after its onset. All patients, except 3, presented associated postoperative complications and 4 patients died. The characteristics of vasoplegic syndrome are similar to those observed in septic shock, where the alterations are mediated by cytokines and tumor necrosis factor-alpha.
CONCLUSIONS: The appearance of vasoplegic syndrome augmented operative morbidity with a consequent increased risk to the patient in the early postoperative period.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9833722

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  22 in total

1.  Trans-aortic counterpulsation: a viable alternative?

Authors:  Bharat Datt; Lisa Hutchison; Charles Peniston
Journal:  J Extra Corpor Technol       Date:  2007-06

2.  Risk assessment and outcomes of vasoplegia after cardiac surgery.

Authors:  Athanasios Tsiouris; Lynn Wilson; Ala S Haddadin; James J Yun; Abeel A Mangi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-06-13

3.  Perioperative infusion of low- dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-A double-blind randomized study.

Authors:  Georgios Papadopoulos; Eleni Sintou; Stavros Siminelakis; Efstratios Koletsis; Nikolaos G Baikoussis; Efstratios Apostolakis
Journal:  J Cardiothorac Surg       Date:  2010-03-28       Impact factor: 1.637

4.  Methylene blue treatment for cytokine release syndrome-associated vasoplegia following a renal transplant with rATG infusion: A case report and literature review.

Authors:  John T Denny; Andrew T Burr; Fred Balzer; James T Tse; Julia E Denny; Darrick Chyu
Journal:  Exp Ther Med       Date:  2015-03-12       Impact factor: 2.447

5.  Haemostatic management for aortic valve replacement in a patient with advanced liver disease.

Authors:  Laurence Weinberg; Irene Kearsey; Clarissa Tjoakarfa; George Matalanis; Sean Galvin; Scott Carson; Rinaldo Bellomo; Larry McNicol; Peter McCall
Journal:  World J Clin Cases       Date:  2014-10-16       Impact factor: 1.337

6.  Vasoplegic syndrome after off-pump coronary artery bypass surgery: an unusual complication.

Authors:  Shahzad G Raja; Gilles D Dreyfus
Journal:  Tex Heart Inst J       Date:  2004

Review 7.  Methylene blue-induced methemoglobinemia during cardiopulmonary bypass? A case report and literature review.

Authors:  Craig M McRobb; David W Holt
Journal:  J Extra Corpor Technol       Date:  2008-09

8.  Norepinephrine for hypotensive vasodilatation after cardiac surgery: impact on renal function.

Authors:  Hiroshi Morimatsu; Shigehiko Uchino; John Chung; Rinaldo Bellomo; Jai Raman; Brian Buxton
Journal:  Intensive Care Med       Date:  2003-05-22       Impact factor: 17.440

9.  Pre-existing endothelial cell activation predicts vasoplegia after mitral valve surgery.

Authors:  Kirsten A Kortekaas; Jan H N Lindeman; Marlies E J Reinders; Meindert Palmen; Robert J M Klautz; Philip G de Groot; Mark Roest
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-06-04

10.  A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.

Authors:  Joshua Manghelli; Lisa Brown; Hany B Tadros; Nabil A Munfakh
Journal:  Tex Heart Inst J       Date:  2015-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.